- BNF:
- 8.2.2
- Status:
- Red
- Decision Date:
- None
Comments
RED:
- NICE TA481: Immunosuppressive therapy for kidney transplant in adults. (Includes basiliximab or immediate-release tacrolimus or mycophenolate mofetil). (Decision date - November 2017)
- NICE TA482: Immunosuppressive therapy for children and young people. (Includes basiliximab or immediate-release tacrolimus or mycophenolate mofetil). (Decision date - November 2017)
NHS England drug. To be used in line with NHS England commissioning intentions.
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again
